Chronic Disease Major Risk Factor for Cancer, Cancer Mortality

Share this content:
Chronic Disease Major Risk Factor for Cancer, Cancer Mortality
Chronic Disease Major Risk Factor for Cancer, Cancer Mortality

FRIDAY, Feb. 2, 2018 (HealthDay News) -- Chronic disease is associated with a substantial proportion of the risk of incident cancer and cancer mortality, according to a study published online Jan. 31 in The BMJ.

Huakang Tu, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues followed 405,878 participants for an average of 8.7 years in a prospective cohort study. Participants underwent measurement or diagnosis according to standard methods for cardiovascular disease markers, diabetes, chronic kidney disease markers, pulmonary disease, and a gouty arthritis marker.

The researchers found that apart from blood pressure and pulmonary disease, there was a significantly increased risk of incident cancer for the diseases and markers individually, with adjusted hazard ratios varying from 1.07 to 1.44. There was a statistically significant association for all eight diseases and markers with the risk of cancer death, with adjusted hazard ratios varying from 1.12 to 1.7. There was a positive correlation for chronic disease risk scores summarizing the eight diseases and markers with cancer risk in a dose-response manner; the highest scores were correlated with a 2.21-fold increase in cancer incidence and a four-fold increase in cancer mortality. There was a correlation for high chronic disease scores with substantial years of life lost (13.3 and 15.9 years of life lost in men and women, respectively, for the highest scores).

"Chronic disease is an overlooked risk factor for cancer, as important as five major lifestyle factors combined," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »